← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Natriumcromoglicat (Ph.Eur.); Reproterolhydrochlorid currently has availability issues reported in 1 European register: Germany.
Shortage ATC R03AK05 · also listed as: Natriumcromoglicat (Ph.Eur.); Reproterolhydrochlorid · data refreshed 28 August 2026
As of 28 August 2026, 1 of the 9 tracked registers list current availability issues for Natriumcromoglicat (Ph.Eur.); Reproterolhydrochlorid, covering 1 affected product presentation. Where agencies state a cause, unexpectedly high demand lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2027-03-01; the earliest is 2027-03-01. Registers in Germany indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Natriumcromoglicat (Ph.Eur.); Reproterolhydrochlorid is coded R03AK05 — a medicine acting on the respiratory system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage Allergospasmin N | 2026-08-27 | 2027-03-01 | Erhöhte Nachfrage Alternatives: N/A | register ↗ |
Every individual register entry for Natriumcromoglicat (Ph.Eur.); Reproterolhydrochlorid in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇩🇪 DE | Allergospasmin N | Shortage | 2026-08-27 | 2027-03-01 | Erhöhte Nachfrage |
Yes. As of 28 August 2026, availability issues are reported in: Germany. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2027-03-01 to 2027-03-01. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Natriumcromoglicat (Ph.Eur.); Reproterolhydrochlorid: BfArM (Germany). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Natriumcromoglicat (Ph.Eur.); Reproterolhydrochlorid — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/natriumcromoglicat-ph-eur-reproterolhydrochlorid/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Natriumcromoglicat (Ph.Eur.); Reproterolhydrochlorid availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/natriumcromoglicat-ph-eur-reproterolhydrochlorid/">Natriumcromoglicat (Ph.Eur.); Reproterolhydrochlorid shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>